The First International Symposium on Nanomedicine in Drug Delivery and Cancer Diagnosis will be held Aug. 16-17 at the University of Delaware.

Nanomedicine Conference 2012

August symposium to feature international slate of keynote speakers


3:13 p.m., June 12, 2012--The University of Delaware will host the First International Symposium on Nanomedicine in Drug Delivery and Cancer Diagnosis from Aug. 16-17 at Clayton Hall.

The symposium will bring together international experts to address design, development and evaluation of nanoconstructs for early detection of disease and for delivery of therapeutic and diagnostic agents. Talks will focus on the relationship between the physiochemical properties of nanosystems and their biomedical applications.

Research Stories

Video games and body image

A University of Delaware researcher has surveyed video game players about their views of characters with unrealistic bodies.

CHS lecture series

The College of Health Sciences 2015-16 Distinguished Scholars Lecture Series begins Oct. 8 with a discussion of the effects of aging on neuromuscular adaptions.

“We really want to emphasize what a great opportunity this meeting will be for UD researchers from a variety of departments and disciplines to learn about the state of the art in nanomedicine and to interact with experts from around the world,” said symposium chair Arun Kumar, assistant professor in the Department of Medical Laboratory Science.

“There is tremendous need for the discovery and development of innovative technologies to improve the delivery of therapeutic and diagnostic agents in the body, and nanotechnology has the potential to make a significant impact in these areas of health care. We’re looking forward to a strong contingent of international experts joining us for this meeting, and we encourage UD faculty in related fields to submit abstracts and plan to attend.”

The deadline for abstract submission is June 30. Guidelines, templates and instructions are available on the website

Keynote speakers include the following:

  • Meyya Meyyappan, Center for Nanotechnology, NASA Ames Research Center (U.S.)
  • Donald Martin, Université Joseph Fourier (France)
  • Kattesh V. Katti, University of Missouri Cancer Nanotechnology (U.S.)
  • Adam Friedman, Albert Einstein College of Medicine (U.S.)
  • Már Másson, School of Health Science, University of Iceland (Iceland)
  • Brabara Zavan, University of Padova (Italy)
  • Bruce M Boman, Helen F. Graham Cancer Center (U.S.)
  • Alexei Bogdanov, Jr., University of Massachusetts Medical School (U.S.)
  • Steven K. Libutti, Montefiore-Einstein Center for Cancer Care (U.S.)

Article by Diane Kukich

icon-fb icon-tw icon-yt icon-fs

News Media Contact

University of Delaware
Communications and Public Affairs

UDaily is produced by
Communications and Public Affairs

The Academy Building
105 East Main Street
University of Delaware
Newark, DE 19716 | USA
Phone: (302) 831-2792
University of Delaware • Newark, DE 19716 • (302) 831-2792 • ©2012
University of Delaware • Newark, DE 19716 • USA • Phone: (302) 831-2792 • © 2013
Comments|Contact Us|Legal Notices